Heat sensitivity of double-stranded DNA-dependent protein kinase (DNA-PK) activity

被引:26
|
作者
Ihara, M
Suwa, A
Komatsu, K
Shimasaki, T
Okaichi, K
Hendrickson, EA
Okumura, Y
机构
[1] Nagasaki Univ, Sch Med, Atom Bomb Dis Inst, Dept Radiat Biophys, Nagasaki 8528523, Japan
[2] Tokyo Metropolitan Ohtsuka Hosp, Div Rheumat Dis, Tokyo 1708476, Japan
[3] Hiroshima Univ, Res Inst Nucl Med & Biol, Dept Radiat Biol, Hiroshima 7348553, Japan
[4] Brown Univ, Div Biol & Med, Providence, RI 02912 USA
关键词
D O I
10.1080/095530099140717
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Purpose: The heat sensitivity of DNA-PK activity in hybrid cells and the possible restoration of this activity with extracts from scid cells (defective in DNA-PKcs), sxi-3 cells (defective in Ku80) and V79-4 (sxi-3 parental wild-type cells) was analysed. Materials and methods: Heat treatment of cells was performed in a water bath at 44 degrees C. The cell extract from scid cells or sxi-3 cells was added to heat-treated hybrid cell extracts, and the DNA-PK activity was assayed. Results: When hybrid cells were heated at 44 degrees C for 15 min, DNA-PK activity was reduced to undetectable levels. The decreased DNA-PK activity could be restored in a concentration-dependent manner with the addition of scid cell extract. The sxi-3 cell extract could not restore heat-inactivated DNA-PK activity. Conclusions: DNA-PK was inactivated by heat treatment at 44 degrees C. Ku70/Ku80, but not Ku70 alone, could restore heat-inactivated DNA-PK.
引用
收藏
页码:253 / 258
页数:6
相关论文
共 50 条
  • [31] DEVELOPMENT OF DNA-DEPENDENT PROTEIN-KINASE (DNA-PK) ASSAY SYSTEM USING HUMAN AUTOANTIBODIES AGAINST THE 350-KDA CATALYTIC SUBUNIT OF DNA-PK
    SUWA, A
    MIMORI, T
    WATANABE, F
    TERAOKA, H
    HIRAKATA, M
    INADA, S
    HARDIN, JA
    ARTHRITIS AND RHEUMATISM, 1995, 38 (09): : 1001 - 1001
  • [32] The human Rad54 recombinational DNA repair protein is a double-stranded DNA-dependent ATPase
    Swagemakers, SMA
    Essers, J
    de Wit, J
    Hoeijmakers, JHJ
    Kanaar, R
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (43) : 28292 - 28297
  • [33] Phosphorylation of native and truncated isoforms of protein tau by the double-stranded DNA-dependent protein kinase (DNA-PK) shows that the primary phosphorylation sites are localized between amino acid residues 212-231 of the longest tau
    Wu, JM
    Chen, YP
    Hsieh, TC
    Brandt, R
    Lee, G
    BIOCHEMISTRY AND MOLECULAR BIOLOGY INTERNATIONAL, 1996, 40 (01): : 21 - 31
  • [34] The DNA-dependent protein kinase (DNA-PK) activity is determinant in the response of chronic lymphocytic leukemia (CLL) lymphocytes to nitrogen mustards (NMs).
    Muller, C
    Christodoulopoulos, G
    Salles, B
    Panasci, L
    BLOOD, 1998, 92 (10) : 385A - 385A
  • [35] DNA-dependent protein kinase (DNA-PK) regulates V(D)J recombination by RAG2 phosphorylation
    Kim, DR
    Choi, Y
    Son, YM
    Hah, YS
    FEBS JOURNAL, 2005, 272 : 290 - 291
  • [36] Atropisomeric 8-arylchromen-4-ones exhibit enantioselective inhibition of the DNA-dependent protein kinase (DNA-PK)
    Cano, Celine
    Golding, Bernard T.
    Haggerty, Karen
    Hardcastle, Ian R.
    Peacock, Marcus
    Griffin, Roger J.
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2010, 8 (08) : 1922 - 1928
  • [37] Preclinical characterization of the selective DNA-dependent protein kinase (DNA-PK) inhibitor VX-984 in combination with chemotherapy
    Boucher, D.
    Hillier, S.
    Newsome, D.
    Wang, Y.
    Takemoto, D.
    Gu, Y.
    Markland, W.
    Hoover, R.
    Arimoto, R.
    Maxwell, J.
    Fields, S. Z.
    Charifson, P.
    Penney, M. S.
    Tanner, K.
    ANNALS OF ONCOLOGY, 2016, 27
  • [38] The DNA-activated protein kinase - DNA-PK
    Anderson, CW
    Carter, TH
    MOLECULAR ANALYSIS OF DNA REARRANGEMENTS IN THE IMMUNE SYSTEM, 1996, 217 : 91 - 111
  • [39] DNA ligase I activation during repair of alkylation damaged DNA is via DNA-dependent protein kinase (DNA-PK) mediated phosphorylation
    Bhat, KR
    Benton, BJ
    Ray, R
    FASEB JOURNAL, 1999, 13 (07): : A1453 - A1453
  • [40] A novel, selective inhibitor of DNA-dependent protein kinase (DNA-PK) potentiates the effects of DNA-damaging therapies in hepatocellular carcinoma
    Willoughby, Catherine E.
    Thomas, Huw D.
    Rennison, Tommy
    Cano, Celine
    Reeves, Helen L.
    Wedge, Stephen R.
    CANCER RESEARCH, 2017, 77